GSK now owns 8.9% of PATH and the have a new FDA approved drug.
Take a look at PATH, GSK now owns over 8.9% and other major investors have over 50% in the company. This small company says they want to partner or get bought out, view CEO annual review. Very low float, High Option investment, talks are going on about partnership or buyout and take over of PATH. This will be a 3-4 times pop on buyout easy. Do some DD and you will find many reasons to buy PATH. Oh yea CEO took major stock investment along with small pay to come from a billion dollar company to PATH and GSK owns 8.9% and is only 2 miles from GSK.